The University of Chicago Header Logo

Connection

Jeffrey Hubbell to Recombinant Proteins

This is a "connection" page, showing publications Jeffrey Hubbell has written about Recombinant Proteins.
Connection Strength

1.416
  1. Drug development: Longer-lived proteins. Nature. 2010 Oct 28; 467(7319):1051-2.
    View in: PubMed
    Score: 0.318
  2. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part I: Development and physicochemical characteristics. Biomacromolecules. 2005 May-Jun; 6(3):1226-38.
    View in: PubMed
    Score: 0.217
  3. Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules. 2002 Jul-Aug; 3(4):710-23.
    View in: PubMed
    Score: 0.179
  4. Engineered bridge protein with dual affinity for bone morphogenetic protein-2 and collagen enhances bone regeneration for spinal fusion. Sci Adv. 2021 06; 7(24).
    View in: PubMed
    Score: 0.166
  5. Engineering growth factors for regenerative medicine applications. Acta Biomater. 2016 Jan; 30:1-12.
    View in: PubMed
    Score: 0.113
  6. The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine. Sci Rep. 2015 Feb 24; 5:8569.
    View in: PubMed
    Score: 0.107
  7. Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164. Proc Natl Acad Sci U S A. 2014 May 13; 111(19):6952-7.
    View in: PubMed
    Score: 0.101
  8. Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2. Biomaterials. 2004 Jul; 25(16):3245-57.
    View in: PubMed
    Score: 0.051
  9. Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro. Microvasc Res. 2001 Nov; 62(3):315-26.
    View in: PubMed
    Score: 0.043
  10. Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain. PLoS One. 2013; 8(4):e62076.
    View in: PubMed
    Score: 0.024
  11. Engineered insulin-like growth factor-1 for improved smooth muscle regeneration. Biomaterials. 2012 Jan; 33(2):494-503.
    View in: PubMed
    Score: 0.021
  12. Toxicity and exposure of an adenovirus containing human interferon alpha-2b following intracystic administration in cynomolgus monkeys. Gene Ther. 2012 Jul; 19(7):742-51.
    View in: PubMed
    Score: 0.021
  13. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. Biomacromolecules. 2006 Nov; 7(11):3019-29.
    View in: PubMed
    Score: 0.015
  14. Neurite extension and in vitro myelination within three-dimensional modified fibrin matrices. J Neurobiol. 2005 Apr; 63(1):1-14.
    View in: PubMed
    Score: 0.014
  15. Effects of protein and gene transfer of the angiopoietin-1 fibrinogen-like receptor-binding domain on endothelial and vessel organization. J Biol Chem. 2005 Jun 10; 280(23):22445-53.
    View in: PubMed
    Score: 0.013
  16. Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices. J Orthop Res. 2004 Mar; 22(2):376-81.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.